Search Results for
M15-954Safety And Efficacy Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Complete Remission and Overall Survival In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome (Verona)
Continue Reading »Connect
Connect® MDS/AML Disease Registry
Continue Reading »NHLBI MDS
The National Myelodysplastic Syndromes (MDS) Study
Continue Reading »